Old Web
English
Sign In
Acemap
>
authorDetail
>
Yinuo Pang
Yinuo Pang
AbbVie
Risankizumab
Pharmacokinetics
Medicine
Psoriasis
Tolerability
4
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetic Comparability of Risankizumab Formulations in Prefilled Syringe and Auto-injector for Subcutaneous Injection.
2021
Clinical Therapeutics
Hoi-Kei Lon
Ling Cheng
Sai Nudurupati
Ralf Loebbert
Rachel Duan
Jasmina Kalabic
Yinuo Pang
Show All
Source
Cite
Save
Citations (1)
Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study.
2021
Journal of Crohns & Colitis
Marc Ferrante
Brian G. Feagan
Julián Panés
Filip Baert
Edouard Louis
Olivier Dewit
Arthur Kaser
W Rachel Duan
Yinuo Pang
Wan-Ju Lee
Dawn Gustafson
Xiaomei Liao
Kori Wallace
Jasmina Kalabic
Geert R. DHaens
Show All
Source
Cite
Save
Citations (3)
Clinical Pharmacokinetics and Pharmacodynamics of Risankizumab in Psoriasis Patients
2019
Clinical Pharmacokinectics
Yinuo Pang
Amit Khatri
Ahmed Abbas Suleiman
Ahmed A. Othman
Show All
Source
Cite
Save
Citations (11)
Pharmacokinetics of Risankizumab in Asian Healthy Subjects and Patients With Moderate to Severe Plaque Psoriasis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis
2019
The Journal of Clinical Pharmacology
Amit Khatri
Doerthe Eckert
Rajneet K. Oberoi
Ahmed Abbas Suleiman
Yinuo Pang
Ling Cheng
Ahmed A. Othman
Show All
Source
Cite
Save
Citations (13)
1